Bank of Montreal’s Kyntra Bio KYNB Stock Holding History

Bank of Montreal’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-468	Closed	-$398K	–	4680
2020 Q1	$398K	Buy	+468	New	+$465K	﹤0.01%	2084

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Bank of Montreal's KYNB Position: Q3 2022 in Review

Bank of Montreal sold out of Kyntra Bio (KYNB) in Q3 2022, closing a stake of 4,249 shares — an estimated $1.24K sold.

Bank of Montreal first reported a position in KYNB in Q1 2015 and held it in 20 quarters. The position peaked at $2.49M in Q3 2019. 152 funds tracked by Wall St. Rank hold KYNB as of Q3 2022.

Bank of Montreal reported no remaining Kyntra Bio position as of Q3 2022 after selling out during the quarter.
Bank of Montreal sold 4,249 Kyntra Bio shares in Q3 2022, an estimated $1.24K.
Bank of Montreal first reported a position in Kyntra Bio in Q1 2015 and held it in 20 quarters.
Bank of Montreal's Kyntra Bio position peaked at $2.49M in Q3 2019.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.